Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kenny Kwok Hei Yu"'
Autor:
Anna Skakodub, Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan, Bob T. Li, Nelson S. Moss, Kenny Kwok Hei Yu, Boris A. Mueller, Simon Powell, Pedram Razavi, Helena A. Yu, Jorge S. Reis-Filho, Daniel Gomez, Nikolaus Schultz, Luke R. G. Pike
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract Up to 50% of patients with non-small cell lung cancer (NSCLC) develop brain metastasis (BM), yet the study of BM genomics has been limited by tissue access, incomplete clinical data, and a lack of comparison with paired extracranial specimen
Externí odkaz:
https://doaj.org/article/196398554f514538b9c845b3e2cb07b5
Autor:
Jonathan Khan, Winson Cai, Yanhong Yang, Lauren Dong, Kelsey Hopland, Kenny Kwok-Hei Yu, Ruby Freeman, Terence Purdon, Viviane Tabar, Taha Merghoub, Jedd Wolchok, Renier Brentjens
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Kenny Kwok-Hei Yu, Jessica T Taylor, Omar N Pathmanaban, Amir Saam Youshani, Deniz Beyit, Joanna Dutko-Gwozdz, Roderick Benson, Gareth Griffiths, Ian Peers, Peter Cueppens, Brian A Telfer, Kaye J Williams, Catherine McBain, Ian D Kamaly-Asl, Brian W Bigger
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193694 (2018)
Glioblastoma (GBM) is the most common primary brain malignancy in adults, yet survival outcomes remain poor. First line treatment is well established, however disease invariably recurs and improving prognosis is challenging. With the aim of personali
Externí odkaz:
https://doaj.org/article/c0919e2e2f8a4abbb588898382f3d76c
Autor:
Henry Walch, Anna Skakodub, Kathryn R. Tringale, Harish N. Vasudevan, Jordan Eichholz, Daniel W. Kelly, Emily Lebow, Nelson S. Moss, Kenny Kwok Hei Yu, Bob T. Li, Boris Mueller, Atif Khan, Yao Yu, Simon Powell, Jorge S. Reis-Filho, Brandon S. Imber, Pedram Razavi, Daniel R. Gomez, Nikolaus Schultz, Luke R. Pike
Publikováno v:
Cancer Research. 83:6063-6063
Intro: Half of all patients with NSCLC develop BM during their clinical course. While modern NSCLC-directed agents yield excellent systemic response, most patients require focal BM treatment. Prior reports of BM genomics have been limited by low numb
Autor:
Anna Skakodub, Kathryn Ries Tringale, Henry S. Walch, Harish Vasudevan, Jordan Eichholz, Daniel W. Kelly, Nelson S. Moss, Kenny Kwok Hei Yu, Bob T. Li, Boris Mueller, Jonathan T. Yang, Kathryn Beal, Brandon S. Imber, Daniel Richard Gomez, Nikolaus Schultz, Luke Roy George Pike
Publikováno v:
Journal of Clinical Oncology. 40:2008-2008
2008 Background: Approximately 30% of patients with NSCLC present with BM, and up to 50% of patients ultimately develop BM. While modern NSCLC-directed agents yield excellent systemic response, most patients require focal treatment. Prior reports of
Publikováno v:
BMJ Case Reports. 14:e245369
Brain metastases (BrM) are treated with multimodality therapy, however the optimal combination and timing of modalities in the setting of recurrent tumours that have failed prior treatments remain poorly defined. We present a case of a patient with b